Clinical Trials in Philadelphia

Showing 5201-5220 of 20,904 trials

Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2

NCT06283459

This is an open-label phase 1/2, dose-escalation study. Participants will receive a single intramuscular (IM) dose of IMNN-101 on Day 0 in the deltoid muscle and will be followed through 12 months post-vaccination (through Study Day 365).

SARS CoV 2 Infection

Imunon24 participantsStarted Jun 2024

Boston, Massachusetts, United States • Philadelphia, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

NCT03823287

This study will evaluate the efficacy, safety, durability, and pharmacokinetics of faricimab administered at intervals as specified in the protocol, compared with aflibercept once every 8 weeks (Q8W), in participants with neovascular age-related macular degeneration (nAMD).

Wet Macular Degeneration

Hoffmann-La Roche671 participantsStarted Feb 2019

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +158 more locations

Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

Find Trials by Condition in Philadelphia

Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2)

PaTH Clinical Data Research Network (CDRN) Atrial Fibrillation (AF) Clinician-Patient Partnership Cohort

Secur-Fit Advanced Outcomes Study

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma

A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)

Study Evaluating the Safety and Efficacy of AR-15512

Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3)

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients

Treatment and Duration Effect of Pentosan Polysulfate Sodium (PPS) in Participants With Knee Osteoarthritis Pain